Pharmaceutical composition for preventing or treating benign prostatic hyperplasia
AssigneeUniversity-Industry Cooperation Group of Kyung Hee University
InventorsHYO-JIN AN, BO-RAM JIN
Life of this patent
Estimating the term…
Abstract
Provided are a pharmaceutical composition, a health functional food, and a method for preventing or treating benign prostatic hyperplasia (BPH). The present invention includes mitoquinone as an active ingredient and inhibits the androgen receptor (AR) and nucleotide oligomerization domain (NOD)-like receptor family pyrin domain-containing 3 (NLRP3) signaling pathways to alleviate pathological prostatic hypertrophy and exhibit anti-proliferative and antioxidant effects. Therefore, it can be effectively used in preventing, treating, or ameliorating BPH.
Claims13
A pharmaceutical composition for preventing or treating benign prostatic hyperplasia (BPH), comprising mitoquinone or a pharmaceutically acceptable salt thereof.
A health functional food for preventing or ameliorating benign prostatic hyperplasia (BPH), comprising mitoquinone or a stiologically acceptable salt thereof.
A method of treating benign prostatic hyperplasia (BPH), the method comprising administering to a patient in need of treatment mitoquinone, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition including mitoquinone.
Dependencies are inferred from the claim text.